Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
Precision small molecule drugs for obsessive-compulsive disorder
Serenatis Bio is a preclinical-stage biotech developing small molecule drugs to treat obsessive-compulsive disorder (OCD). Its pipeline of three candidates targets distinct…
Mixed-use science and technology park near Cambridge
Vision Park is a science, technology and finance business park located in Histon, approximately three miles north of Cambridge city centre. The park hosts a diverse range of…
Large-scale genomics research institute advancing human and pathogen biology
The Wellcome Sanger Institute is a genomics research institute on the Wellcome Genome Campus in Hinxton, funded by Wellcome. It made the largest single contribution to the Human…
2D barcoded sample storage tubes and automated handling equipment
AltemisLab is a Cambridge-based manufacturer of 2D barcoded sample storage tubes, barcode readers, and automated capping and decapping equipment for laboratory sample management.…
Small molecule therapeutics targeting astrocytes in Parkinson's disease
Cellestial Health is a pre-clinical stage biotechnology company and University of Cambridge spinout developing small molecule therapeutics for Parkinson's disease and other…
Cambridge R&D hub for GPCR-based drug discovery
Nxera Pharma UK is the Cambridge-based drug discovery arm of Tokyo-listed Nxera Pharma, formerly Sosei Heptares, operating from Granta Park with approximately 170 scientists. Its…
Biomimetic cell culture platform for reproducible cell therapy development
Stembond Technologies is a Cambridge University spin-out developing a synthetic, mechanically tuned biomimetic substrate that replicates the physical properties of human tissue…
Fragment-based drug discovery platform for oncology and CNS disorders
Astex Pharmaceuticals is a drug discovery and development company pioneering fragment-based drug discovery through its proprietary Pyramid platform, applied to oncology and…
Birthplace of molecular biology researching fundamental processes in human disease
The MRC Laboratory of Molecular Biology researches fundamental biological processes at the level of atoms, molecules, cells and organisms, applying this knowledge to major…
CRISPR-engineered tumour-infiltrating lymphocyte therapy
Intima Bioscience is a clinical-stage biotechnology company developing CRISPR gene-edited tumour-infiltrating lymphocyte therapies for solid tumours. Its platform targets CISH, an…
Pharma-university venture funding early-stage translational research
Apollo Therapeutics is a biopharma company advancing therapeutic programmes derived from research at partner universities including Cambridge, Imperial College London, UCL, King's…
Technology transfer and commercialisation office of the University of Cambridge
Cambridge Enterprise is the commercialisation arm of the University of Cambridge, supporting the translation of university research into commercial ventures. It manages…